Comment on article: “Blood products with autologous transfusion versus allogeneic transfusion in cardiac surgery patients”
Main Article Content
Keywords
Patient Blood Management, Thoracic Surgery, Blood Transfusion
Abstract
Evaluating transfusion options helps reduce the use of blood products and improve their distribution. The study “Blood products with autologous transfusion versus allogeneic transfusion in cardiac surgery patients” shows a comparison between the options available to improve blood management in patients in the surgical stage. We ask the authors for more information on the data analysis performed to improve the understanding of the conclusions obtained.
References
Quispe-Fernández LA, Carrillo-González ML, Gutiérrez-Ospina A, Gómez-Leandro II. Hemocomponentes con transfusión autóloga frente a transfusión alogénica en pacientes de cirugía cardiaca. Rev Med Inst Mex Seguro Soc. 2020;58(4):417-27. doi: 10.24875/RMIMSS.M20000066
World Health Organization. The urgent need to implement patient blood management: policy brief. Geneva, Switzerland: World Health Organization; 2021. Disponible en: https://apps.who.int/iris/ handle/10665/346655.
Talavera JO, Rivas-Ruiz R. Investigación clínica IV. Pertinencia de la prueba estadística. Rev Med Inst Mex Seguro Soc. 2011;49(4): 401-5.
Talavera JO, Rivas-Ruiz R. Investigación clínica X. Del juicio clínico al diseño de cohorte. Rev Med Inst Mex Seguro Soc. 2012;50(4):383-8.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.